- MGC Pharmaceuticals Ltd (OTCPK:MGCLF): FY GAAP EPS of $0.05.
- Revenue of $0.29M (+866.7% Y/Y)
- Press Release
- More news on: MGC Pharmaceuticals Ltd, Earnings news and commentary, Healthcare stocks news, ,
home / stock / mgclf / mgclf news
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
MGC Pharmaceuticals Ltd Company Name:
MGCLF Stock Symbol:
Market:
--News Direct-- Argent BioPharma managing director and CEO Roby Zomer speaks to Proactive's Stephen Gunnion following the company's rebranding from MGC Pharmaceuticals, alongside a comprehensive restructuring. Zomer explained the shift marks a refined focus on the pharmaceutical s...
MGC Pharma Rebrands as Argent BioPharma in Strategic Transformation PR Newswire Embracing Comprehensive Restructuring for a New Biopharmaceutical Era Continuing the Development of MGC Pharma's Innovative Drug Portfolio LONDON , Feb. 13, 2024 /PRNe...
(NewsDirect) MGC Pharmaceuticals Ltd CEO and Managing Director Roby Zomer speaks to Thomas Warner from Proactive London following the completion of a share consolidation and capital raise. With these restructuring initiatives completed, Zomer shares his enthusiasm for the future of th...